Authors
Latest:
Subcutaneous Daratumumab Provides Speedier Multiple Myeloma TreatmentSubcutaneous daratumumab offers shorter clinic visits and high tolerability for patients with multiple myeloma, says Stephanie Mompoint, APRN.
Latest:
Advanced Practice Providers May Hold the Key to Improving Community Clinical Trial InvolvementSeventy-three percent of advanced practice providers reported that they are interested in becoming more involved with clinical trials.
Latest:
The Road Ahead: Future Directions in Metastatic Melanoma TreatmentPanelists discuss the importance of effective communication and multidisciplinary collaboration in managing immunotherapy toxicities and ensuring seamless patient care, while highlighting promising advances in melanoma treatment and the role of telehealth and community outreach in expanding access and improving outcomes.
Latest:
Is a Health Care Price Transparency Revolution at Hand?The Transparency in Coverage Final Rule requires health care payers to unveil all previously secret negotiated prices with in-network providers.
Latest:
Bridging Communication Gaps: Comprehensive Care for Upper GI Cancer TreatmentExperts discuss how to facilitate open communication among the patient, caregivers, and the multidisciplinary team to ensure comprehensive care and alignment on treatment goals.
Latest:
Referral Process With Bispecifics: Challenges and SupportDr Mohan engages with Dr Mann, Nurse Brigle, Nurse Distaso, and Dr Nadeem to explore challenges in the referral process for bispecific therapy, including local health care barriers, and strategies for ensuring consistent patient education and support when care is shared between community and academic centers.
Latest:
Rx Road Map: Vorasidenib for the Treatment of Astrocytoma/OligodendrogliomaThis Rx Road Map outlines the most important information nurses should know when treating patients with astrocytoma or oligodendroglioma with vorasidenib.
Latest:
Optimizing Multidisciplinary Care for ESR1-Mutated Breast Cancer: Strategies and Future DirectionsPanelists discuss strategies for medication adherence and patient education, emphasizing the importance of proactive communication and support from the entire health care team.
Latest:
Referral Process With Bispecifics: Challenges and SupportDr Mohan engages with Dr Mann, Nurse Brigle, Nurse Distaso, and Dr Nadeem to explore challenges in the referral process for bispecific therapy, including local health care barriers, and strategies for ensuring consistent patient education and support when care is shared between community and academic centers.
Latest:
Final Thoughts and Hope for a CurePanelists emphasize the importance of multidisciplinary collaboration, patient education, and advocacy in managing multiple myeloma while expressing optimism about emerging therapies like CAR T cells that offer deeper remissions and improved quality of life.
Latest:
Integrated Behavioral Health Vs Standard Practice: What’s The Difference?A licensed clinical health psychologist with Allegheny Health Network discusses fully integrated behavioral health programs and how their design alleviates potential barriers to care that patients may experience.
Latest:
IMvigor011 Confirms ctDNA-Guided Care in Bladder CancerIMvigor011 showed significant improvement in survival outcomes with adjuvant atezolizumab in ctDNA-positive MIBC.
Latest:
Bridging Communication Gaps: Comprehensive Care for Upper GI Cancer TreatmentExperts discuss how to facilitate open communication among the patient, caregivers, and the multidisciplinary team to ensure comprehensive care and alignment on treatment goals.
Latest:
Adding Nivolumab to Chemo Increases OS, PFS in Previously Untreated Advanced GI CancersOverall survival and progression-free survival improves with nivolumab plus chemotherapy compared with chemotherapy alone in the overall population and in patients with a PD-L1 CPS of 5 or greater.
Latest:
Galinsky Breaks Down Venetoclax Symptom Management in AMLIlene Galinsky, BSN, MSN, ANP-C, underscores effective symptom management strategies when prescribing venetoclax to patients with acute myeloid leukemia.
Latest:
Monitoring Severe Adverse Effects of Bispecifics in Multiple MyelomaLisa Hwa Christenson, DNP, CNP, FAPO, shares best practices for monitoring CRS and ICANS with BCMA bispecific antibodies in community oncology.
Latest:
Normalize Conversations Between Patients and Providers on the Financial Costs of CancerNearly half of patients with gynecologic cancer reported financial distress as a result of the high costs of cancer treatment, yet money is still not commonly discussed between patients and providers.
Latest:
Brenda Martone Highlights Nursing Considerations With Darolutamide in Prostate CancerBrenda Martone MSN, ANP-BC, AOCNP, discusses what nurses need to know about safely treating patients with darolutamide.
Latest:
Oncology Drug Crash Course: Nivolumab Plus Relatlimab (Opdualag)Jeanelle S. King, PA-C, provides an in-depth look at nivolumab-relatlimab in a downloadable reference sheet.
Latest:
Gretchen McNally Speaks to the Role of Oncology Nurses in the Opioid EpidemicGretchen McNally PhD, ANP-BC, AOCN, spotlights the value that naloxone training for oncology nurses and providers could have for patients who are at a high-risk of overdose.
Latest:
Finding the Small WinsThe winner of the 2024 Extraordinary Healer® award, Meaghan Mooney, BSN, RN, OCN, found a rewarding career caring for patients and their families, even after transitioning to a leadership role. Now, she uses her expertise to help children facing a parent's cancer diagnosis.
Latest:
Rx Road Map: Enfortumab Vedotin (Padcev)Srigowri Kota, MSN, BA, APRN, AGNP-C, AOCNP, provides an in-depth look at enfortumab vedotin for the treatment of patients with urothelial cancer in a downloadable reference sheet.
Latest:
Anthracyclines Boost Survival, Increases Hospital Time in AMLOlder adults with acute myeloid leukemia treated with anthracyclines tended to live longer, but also had more time spent in the hospital compared with those treated with HMAs.
Latest:
Opinion: Nursing Considerations for Emerging CLDN6-Targeted TherapiesUnderstanding which patients may benefit from CLDN6-targeting immunotherapy and recognizing potential adverse effects is essential for oncology nurses.
Latest:
Complex Cancer Cases: Veno-Occlusive Disease in a Pediatric Patient Receiving Nontransplant-Associated ChemotherapyVeno-occlusive disease or sinusoidal obstruction syndrome is commonly associated as a complication with transplant in pediatric patients but can also be seen with chemotherapy alone.
Latest:
Patients With Cancer May Need Help Changing Their Eating ApproachesCaitlin Benda, MBA, MS, RD, CSO, LDN, a clinical oncology nutritionist supervisor at American Oncology Network, comments on different ways oncology nurses can assist patients in reaching their overall caloric intake.
Latest:
Recognition of the Advanced Practice Preceptor Role in OncologyA tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Latest:
Power of Palliative Care: How Oncology Nurses Can Increase ReferralsA nurse-driven palliative care referral intervention demonstrated preliminary success in increasing the number of patients who received this form of supportive care.
Latest:
Opioid Reduction in Surgical Oncology Supported by Cultural ShiftA significant reduction of opioid use in patients after colorectal surgery was supported by clinician and patient compliance, says Ronald Bleday, MD.
